NCT07202273View on ClinicalTrials.gov

Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Bone Metastases
Interventions
RADIATION

simulation-free, single-fraction palliative radiation therapy

Radiation will be delivered in a single fraction. The recommended prescription dose is 8 Gy with external beam radiation therapy.

Trial Locations (1)

84112

Huntsman Cancer Institute/University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT07202273 - Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases | Biotech Hunter | Biotech Hunter